Waldron Private Wealth LLC
- SEC CIK
- 0001598180
- Latest filing
- Jul 20, 2026
TCRX holding history
TScan Therapeutics, Inc. in every 13F filed by Waldron Private Wealth LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
TCRX overviewAll 13F holders of TCRXFull Q2 2026 holdings
- Shares (Q1 2026)
- 0
- Sold out in Q1 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 12
- Since Q1 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2026 | 0 | $0 | 0.0% | −10,000−100.0% | Sold out | Holders |
| Q4 2025 | 10,000 | $10.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 10,000 | $18.2K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 10,000 | $14.5K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 10,000 | $13.8K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 10,000 | $30.4K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 10,000 | $49.8K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 10,000 | $58.5K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 10,000 | $79.4K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 10,000 | $58.3K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 10,000 | $25.6K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 10,000 | $25.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 10,000 | $21.0K | <0.1% | +10,000 | New | Holders |